MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Quotient Limited Total Shareholders Equity 2011-2026 | QTNT
Annual Total Shareholders Equity Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -35.6 M | 2.24 M | 1.71 M | -14.6 M | -24.1 M | 46.7 M | -1.62 M | -31.5 M | -23.1 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.7 M | -35.6 M | -8.87 M |
Quarterly Total Shareholders Equity Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -209 M | -182 M | -151 M | -144 M | -126 M | -85.3 M | -61.2 M | -35.6 M | 2.24 M | 7.67 M | 33.7 M | -30.2 M | 18.1 M | 18.1 M | -46.9 M | -21.2 M | 24.7 M | 24.7 M | -14.7 M | -15.2 M | 3.82 M | -16.4 M | 4.47 M | -24.1 M | -5.08 M | 27.4 M | 27.9 M | 46.7 M | 26.1 M | 9.66 M | -8.36 M | -1.62 M | -7.94 M | 9.9 M | 23.4 M | -31.5 M | - | - | - | -23.1 M | - | - | - | -18.7 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 46.7 M | -209 M | -25 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
CareDx, Inc
CDNA
|
303 M | $ 21.13 | 1.51 % | $ 1.13 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Agilent Technologies
A
|
5.39 B | $ 115.13 | -0.36 % | $ 35 B | USA |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 1.53 | -1.29 % | $ 2.04 M | USA |
 |
Castle Biosciences
CSTL
|
456 M | $ 24.66 | 0.69 % | $ 685 M | USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 14.29 | -5.92 % | $ 432 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 115.11 | -2.73 % | $ 9.49 B |  Irlanda |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 85.08 | 0.54 % | $ 5.74 B | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 415.89 | -0.66 % | $ 12 B | USA |
 |
Illumina
ILMN
|
2.37 B | $ 131.26 | 3.57 % | $ 20.9 B | USA |
 |
NeoGenomics
NEO
|
837 M | $ 9.44 | 1.94 % | $ 1.21 B | USA |
 |
National Research Corporation
NRC
|
14 M | $ 17.17 | 4.31 % | $ 384 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11.9 B | $ 26.5 | 0.61 % | $ 20 B |  Niderland |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
203 M | $ 5.53 | 0.18 % | $ 328 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Senseonics Holdings
SENS
|
61 M | $ 5.13 | -22.39 % | $ 214 M | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 164.81 | -1.29 % | $ 8.17 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 87.91 | 0.95 % | $ 11 B | USA |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 473.92 | -1.05 % | $ 179 B | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 59.17 | 1.23 % | $ 3.54 B | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.91 | 3.37 % | $ 455 M | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.98 | -0.5 % | $ 8.76 M | USA |
 |
Waters Corporation
WAT
|
2.56 B | $ 307.99 | -0.4 % | $ 18.3 B | USA |
 |
Soleno Therapeutics
SLNO
|
450 M | $ 52.86 | 0.08 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
4.1 M | $ 2.18 | - | $ 5.01 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 257.15 | 0.14 % | $ 21.4 B | USA |
 |
Celcuity
CELC
|
101 M | $ 119.5 | -1.52 % | $ 5.59 B | USA |
 |
Natera
NTRA
|
706 M | $ 204.73 | -0.7 % | $ 20.1 B | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.53 | 1.33 % | $ 2.07 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 194.33 | 0.07 % | $ 21.6 B | USA |
 |
OpGen
OPGN
|
7.38 M | - | -16.95 % | $ 1.54 M | USA |